Search

everythinglearnresearchcommunity

for

Search:↓

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Baldness may indicate higher heart disease risk in men.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Patients with mycosis fungoides have a higher risk of heart disease.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Women with pattern hair loss often have higher blood sugar, cholesterol, blood pressure, and waist size, suggesting a link between hair loss and metabolic syndrome.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Male-pattern baldness has a weak link to heart disease and some related health conditions.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

People with androgenetic alopecia are more likely to have metabolic syndrome.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Women with AGA have higher lipid levels, increasing heart disease risk.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.